Drug-coated balloons (DCBs) significantly reduce restenosis in side branches of coronary bifurcation lesions when used in addition to main-vessel drug-eluting stents (DES), suggests a new trial presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference.